Format

Send to

Choose Destination
See comment in PubMed Commons below
MAbs. 2013 Sep-Oct;5(5):626-32. doi: 10.4161/mabs.25300. Epub 2013 Jun 7.

Therapeutic antibodies and infectious diseases, Tours, France, November 20-22, 2012.

Author information

1
Université François-Rabelais de Tours; CEPR - EA 6305 & UMR 7292; Tours, France; CHRU de Tours; Service de Parasitologie - Mycologie - Médecine tropicale et Laboratoire d'Immunologie; Tours, France.

Abstract

The Therapeutic Antibodies and Infectious Diseases international congress was held in Tours, France on November 20-22, 2012. The first session was devoted to the development of antibodies directed against bacterial toxins or viruses that could be used in a potential bioterrorist threat situation. The second session dealt with the effector functions of anti-microbial antibodies, while the third was oriented toward anti-viral antibodies, with a special emphasis on antibodies directed against the human immunodeficiency and hepatitis C viruses. After a lecture by a speaker from the US Food and Drug Administration on antibody cocktails, the second day ended with a special session dedicated to discussions regarding the involvement of French biotechnology industries in the field. On the last day, the congress concluded with talks about current antibody treatments for infectious diseases, with a particular focus on their adverse events. Participants enjoyed this very stimulating and convivial meeting, which gathered scientists from various countries who had different scientific research interests.

KEYWORDS:

antibodies; immunotherapy; infectious diseases; monoclonal

PMID:
23883703
PMCID:
PMC3851213
DOI:
10.4161/mabs.25300
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center